Malta and Italy have signed an agreement for the emergency supply of blood components and the separation and treatment of blood plasma, in a bid to bolster Malta’s preparedness for emergencies.
The agreement was announced in a National Blood Transfusion Service statement Thursday, which described it as a “significant step toward enhancing cross-border healthcare collaboration”.
Blood components include red and white blood cells, protein and platelets, while the separation and treatment of blood plasma, known as plasma fractionation, is used to separate and purify proteins from plasma.
Plasma fractionation, which is in rising demand worldwide, is seen as a “key pillar” of EU strategy for healthcare, the statement read.
The “pivotal” technical agreement is aimed at improving Malta’s capabilities to deal with major accidents, public health crises and natural disasters.
Speaking at the signing ceremony, Permanent Secretary for Health Joseph Chetcuti said that in such instances, “every second counts… highlighting how Italy’s support will provide not only vital medical resources but also invaluable peace of mind”.
The statement noted that Italy, known for its “advanced blood transfusion systems and medical expertise,” was seen as a “natural partner” for Malta.
Malta National Blood Transfusion Service medical director Monique Debattista said the agreement was “not just about a supply chain; it’s about saving lives”.